This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Jan;25(1):96-105.

doi: 10.1016/j.nmd.2014.09.003. Epub 2014 Sep 11.

Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy

Stephen Lynn¹, Annemieke Aartsma-Rus², Kate Bushby¹, Pat Furlong³, Nathalie Goemans⁴, Annamaria De Luca⁵, Anna Mayhew¹, Craig McDonald⁶, Eugenio Mercuri⁷, Francesco Muntoni⁸, Marita Pohlschmidt⁹, Jan Verschuuren¹⁰, Thomas Voit¹¹, Elizabeth Vroom¹², Dominic J Wells¹³, Volker Straub¹⁴

Affiliations

Affiliations

¹ Newcastle University, Newcastle upon Tyne, UK.
² Newcastle University, Newcastle upon Tyne, UK; Leiden University Medical Centre, Leiden, The Netherlands.
³ Parent Project Muscular Dystrophy, Hackensack, NJ, USA.
⁴ University of Leuven, Leuven, Belgium.
⁵ University of Bari, Bari, Italy.
⁶ University of California Davis, Davis, CA, USA.
⁷ Catholic University Rome, Rome, Italy.
⁸ University College London, London, UK.
⁹ Muscular Dystrophy Campaign, London, UK.
¹⁰ Leiden University Medical Centre, Leiden, The Netherlands.
¹¹ University Pierre et Marie Curie Paris 6, Institut de Myologie, UPMC-INSERM UMR 974, CNRS FRE 3617, GH Pitié-Salpêtrière, Paris, France.
¹² Duchenne Parent Project, Amsterdam, The Netherlands.
¹³ Royal Veterinary College, London, UK.
¹⁴ Newcastle University, Newcastle upon Tyne, UK. Electronic address: volker.straub@ncl.ac.uk.

PMID: 25307856
DOI: 10.1016/j.nmd.2014.09.003

Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy

Stephen Lynn et al. Neuromuscul Disord. 2015 Jan.

. 2015 Jan;25(1):96-105.

doi: 10.1016/j.nmd.2014.09.003. Epub 2014 Sep 11.

Authors

Stephen Lynn¹, Annemieke Aartsma-Rus², Kate Bushby¹, Pat Furlong³, Nathalie Goemans⁴, Annamaria De Luca⁵, Anna Mayhew¹, Craig McDonald⁶, Eugenio Mercuri⁷, Francesco Muntoni⁸, Marita Pohlschmidt⁹, Jan Verschuuren¹⁰, Thomas Voit¹¹, Elizabeth Vroom¹², Dominic J Wells¹³, Volker Straub¹⁴

Affiliations

¹ Newcastle University, Newcastle upon Tyne, UK.
² Newcastle University, Newcastle upon Tyne, UK; Leiden University Medical Centre, Leiden, The Netherlands.
³ Parent Project Muscular Dystrophy, Hackensack, NJ, USA.
⁴ University of Leuven, Leuven, Belgium.
⁵ University of Bari, Bari, Italy.
⁶ University of California Davis, Davis, CA, USA.
⁷ Catholic University Rome, Rome, Italy.
⁸ University College London, London, UK.
⁹ Muscular Dystrophy Campaign, London, UK.
¹⁰ Leiden University Medical Centre, Leiden, The Netherlands.
¹¹ University Pierre et Marie Curie Paris 6, Institut de Myologie, UPMC-INSERM UMR 974, CNRS FRE 3617, GH Pitié-Salpêtrière, Paris, France.
¹² Duchenne Parent Project, Amsterdam, The Netherlands.
¹³ Royal Veterinary College, London, UK.
¹⁴ Newcastle University, Newcastle upon Tyne, UK. Electronic address: volker.straub@ncl.ac.uk.

PMID: 25307856
DOI: 10.1016/j.nmd.2014.09.003

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

MR/K000608/1/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information